Literature DB >> 22914560

Risk factors for death and severe sequelae in Malawian children with bacterial meningitis, 1997-2010.

David W McCormick1, Mark L Wilson, Limangeni Mankhambo, Ajib Phiri, Yamikani Chimalizeni, Kondwani Kawaza, Brigitte Denis, Enitan D Carrol, Elizabeth M Molyneux.   

Abstract

BACKGROUND: Acute bacterial meningitis (ABM) causes significant death and disability in children worldwide, with HIV recognized as an established risk factor for infection and negative outcomes. However, additional major risk factors for death and disability in pediatric ABM remain unclear.
METHODS: We conducted a retrospective analysis of case data from 3 departmental studies of ABM involving 1784 children <15 years old who attended Queen Elizabeth Central Hospital in Blantyre, Malawi during 1997 to 2010. Univariate and multivariate logistic regression models were used to estimate the effects of HIV seropositivity, impaired consciousness and causative organism on death and severe sequelae.
RESULTS: Impaired consciousness or coma at the time of admission was strongly associated with death (coma: odds ratio [OR] = 14.4, 95% confidence interval [CI]: 9.42, 22.1) and severe sequelae (Coma: OR = 3.27, 95% CI: 2.02, 5.29) in multivariate logistic regression models. HIV seropositivity was significantly associated with increased odds of death (OR = 1.65, 95% CI: 1.20, 2.26) but not with developing severe sequelae (OR = 0.88, 95% CI: 0.56, 1.38). After adjustment, infection with Salmonella spp. was associated with increased odds of death (OR = 2.11, 95% CI: 1.06, 4.08) and pneumococcal meningitis was associated with increased odds of severe sequelae (OR = 1.84, 95% CI: 1.03, 3.29).
CONCLUSIONS: Impaired consciousness and HIV infection increased the odds of death from ABM in Malawian children. Use of pneumococcal conjugate vaccine could greatly reduce the burden of ABM in Malawi.

Entities:  

Mesh:

Year:  2013        PMID: 22914560      PMCID: PMC3671939          DOI: 10.1097/INF.0b013e31826faf5a

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  30 in total

Review 1.  Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis.

Authors:  Karen Edmond; Andrew Clark; Viola S Korczak; Colin Sanderson; Ulla K Griffiths; Igor Rudan
Journal:  Lancet Infect Dis       Date:  2010-05       Impact factor: 25.071

2.  5 versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study.

Authors:  Elizabeth Molyneux; Shaikh Qamaruddin Nizami; Samir Saha; Khanh Truong Huu; Matloob Azam; Zulfiqar Ahmad Bhutta; Ramadan Zaki; Martin Willi Weber; Shamim Ahmad Qazi
Journal:  Lancet       Date:  2011-05-28       Impact factor: 79.321

3.  Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children.

Authors:  S A Madhi; K Petersen; A Madhi; A Wasas; K P Klugman
Journal:  Pediatr Infect Dis J       Date:  2000-12       Impact factor: 2.129

Review 4.  Burden of meningitis and other severe bacterial infections of children in africa: implications for prevention.

Authors:  H Peltola
Journal:  Clin Infect Dis       Date:  2000-12-11       Impact factor: 9.079

5.  Impact of HIV infection and exposure on survival in critically ill children who attend a paediatric emergency department in a resource-constrained setting.

Authors:  S Ahmad; J C Ellis; H Kamwendo; E M Molyneux
Journal:  Emerg Med J       Date:  2010-06-01       Impact factor: 2.740

6.  Prospective cohort study of disabling sequelae and quality of life in children with bacterial meningitis in urban Senegal.

Authors:  Karen Edmond; Yakou Dieye; Ulla K Griffiths; Jessica Fleming; Ousseynou Ba; Ndiouga Diallo; Kim Mulholland
Journal:  Pediatr Infect Dis J       Date:  2010-11       Impact factor: 2.129

Review 7.  Predicting sequelae and death after bacterial meningitis in childhood: a systematic review of prognostic studies.

Authors:  Rogier C J de Jonge; A Marceline van Furth; Merel Wassenaar; Reinoud J B J Gemke; Caroline B Terwee
Journal:  BMC Infect Dis       Date:  2010-08-05       Impact factor: 3.090

Review 8.  Human immunodeficiency virus infection and pediatric bacterial meningitis in developing countries.

Authors:  Elizabeth Molyneux
Journal:  J Neurovirol       Date:  2005       Impact factor: 2.643

9.  Bacterial meningitis and Haemophilus influenzae type b conjugate vaccine, Malawi.

Authors:  David W McCormick; Elizabeth M Molyneux
Journal:  Emerg Infect Dis       Date:  2011-04       Impact factor: 6.883

10.  Invasive Streptococcus pneumoniae in children, Malawi, 2004-2006.

Authors:  Jennifer E Cornick; Dean B Everett; Caroline Broughton; Brigitte B Denis; Daniel L Banda; Enitan D Carrol; Christopher M Parry
Journal:  Emerg Infect Dis       Date:  2011-06       Impact factor: 6.883

View more
  21 in total

1.  Rapid Accurate Identification of Tuberculous Meningitis Among South African Children Using a Novel Clinical Decision Tool.

Authors:  Anu Goenka; Prakash M Jeena; Koleka Mlisana; Tom Solomon; Kevin Spicer; Rebecca Stephenson; Arpana Verma; Barnesh Dhada; Michael J Griffiths
Journal:  Pediatr Infect Dis J       Date:  2018-03       Impact factor: 2.129

2.  Risk Factors for Death and Major Morbidity in Guatemalan Children with Acute Bacterial Meningitis.

Authors:  Daniel Olson; Molly M Lamb; James T Gaensbauer; James K Todd; Neal A Halsey; Edwin J Asturias
Journal:  Pediatr Infect Dis J       Date:  2015-07       Impact factor: 2.129

3.  Bacterial meningitis in Malawian adults, adolescents, and children during the era of antiretroviral scale-up and Haemophilus influenzae type b vaccination, 2000-2012.

Authors:  Emma C Wall; Dean B Everett; Mavuto Mukaka; Naor Bar-Zeev; Nicholas Feasey; Andreas Jahn; Mike Moore; Joep J van Oosterhout; Paul Pensalo; Kenneth Baguimira; Stephen B Gordon; Elizabeth M Molyneux; Enitan D Carrol; Neil French; Malcolm E Molyneux; Robert S Heyderman
Journal:  Clin Infect Dis       Date:  2014-02-04       Impact factor: 9.079

Review 4.  Osmotic therapies added to antibiotics for acute bacterial meningitis.

Authors:  Emma C B Wall; Katherine M B Ajdukiewicz; Robert S Heyderman; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28

5.  Outcome of acute bacterial meningitis among children in Kandahar, Afghanistan: A prospective observational cohort study.

Authors:  Bilal Ahmad Rahimi; Niamatullah Ishaq; Ghulam Mohayuddin Mudaser; Walter R Taylor
Journal:  PLoS One       Date:  2022-04-11       Impact factor: 3.240

6.  Long-term sequelae of childhood bacterial meningitis.

Authors:  Lee D Hudson; Russell M Viner; Deborah Christie
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

Review 7.  Clinical and Microbiological Features of Salmonella Meningitis in a South African Population, 2003-2013.

Authors:  Karen H Keddy; Arvinda Sooka; Alfred Musekiwa; Anthony M Smith; Husna Ismail; Nomsa P Tau; Penny Crowther-Gibson; Frederick J Angulo; Keith P Klugman
Journal:  Clin Infect Dis       Date:  2015-11-01       Impact factor: 9.079

8.  Viral CNS infections in children from a malaria-endemic area of Malawi: a prospective cohort study.

Authors:  Macpherson Mallewa; Pam Vallely; Brian Faragher; Dan Banda; Paul Klapper; Mavuto Mukaka; Harriet Khofi; Paul Pensulo; Terrie Taylor; Malcolm Molyneux; Tom Solomon
Journal:  Lancet Glob Health       Date:  2013-09       Impact factor: 26.763

9.  Epidemiological Characteristics and Drug Resistance Analysis of Cerebrospinal Fluid Microbial Infections in Wenzhou Area.

Authors:  Teng Zhou; Mengjiao Kuang; Shirui Huang; Jizhen Li; Qipeng Xie
Journal:  Infect Drug Resist       Date:  2021-06-03       Impact factor: 4.003

10.  High mortality amongst adolescents and adults with bacterial meningitis in sub-Saharan Africa: an analysis of 715 cases from Malawi.

Authors:  Emma C Wall; Katharine Cartwright; Matthew Scarborough; Katherine M Ajdukiewicz; Patrick Goodson; James Mwambene; Eduard E Zijlstra; Stephen B Gordon; Neil French; Brian Faragher; Robert S Heyderman; David G Lalloo
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.